NCT00219141 - Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension | Biotech Hunter

Enrollment

460

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

HypertensionLeft Ventricular HypertrophyOverweight

Interventions

DRUG

Aliskiren 150/300 mg

Aliskiren 150 mg tablets

DRUG

Losartan 50/100 mg

Losartan 50 or 100 mg capsules

DRUG

Aliskiren placebo

Aliskiren 150 mg placebo tablet

DRUG

Losartan 50/100 mg placebo

Losartan 50/100 mg placebo capsules

Trial Locations (9)

Novartis Pharmaceuticals, East Hanover

sites in Argentina, Argentina

sites in Colombia, Colombia

sites in Finland, Finland

sites in Germany, Germany

sites in Italy, Italy

sites in Russia, Russia

sites in Spain, Spain

sites in Sweden, Sweden